IFNA1 and asthma: In conclusion, we report that inhibition of NF-κB p65 suppresses airway inflammation but does not impact on host antiviral defence suggesting that while crucial for inflammation, p65 is not critical for IFN gene expression and is therefore an attractive therapeutic target for RV-induced asthma exacerbations.